CIHR – Joint Canada-Israel Health Research Program Phase II (2022 funding opportunity) – Registration

Well-being, Health and Biomedical Discovery


Academic Unit: inquire within your unit

Memorial Deadline: No RIS review required for the Registration

External Deadline: Tuesday 17th, January 2023


Important Dates

Competition 202302JCI
Registration Deadline 2023-01-17
Application Deadline 2023-02-16
Anticipated Notice of Decision 2023-08-08
Funding Start Date 2023-11-01

Phase II of the Joint Canada-Israel Health Research Program (the Program) seeks to support cutting-edge research in the biomedical sciences and global health. This second call for proposals under Phase II is directed toward applicants conducting research in the broad area of Communicable Diseases while strengthening capacity in Canada, Israel and in low- and middle-income countries (LMIC).

The Program will support world-class research projects co-led by three principal investigators: one from Canada, one from Israel and one from an eligible LMIC (see IDRC website for the list of eligible countries). The teams will integrate researchers from all three countries with the intention of strengthening scientific capacity, promoting collaboration, equitable partnerships, and scientific excellence in all its diversity. It is expected that the three principal investigators will work together on a cohesive research project with researchers from all three countries equitably contributing to and benefiting from their involvement in the project and the Program.

Additional information can be found at Researchnet. 

Funding Sources

Canadian Institute of Health Research (CIHR)

This opportunity was posted by: RGCS

Last modified: October 4, 2022